EUVIMEDEUVIMED entdecken
Crossref

Long-term outcomes following successful treatment of acute mesenteric ischemic event: A population-based observational study

Karri Kase, Merli Koitmäe, Annika Reintam Blaser, Kadri Tamme, Peep Talving, Marko Murruste

World Journal of Gastrointestinal Surgery · 27.08.2026 · 18 (8)

DOI: 10.4240/wjgs.118103 ↗

Kurz gefasst

Fachartikel in der Zeitschrift World Journal of Gastrointestinal Surgery, online erschienen am 27.08.2026. Verfasst von Karri Kase und 5 weiteren Autor:innen. Die Arbeit nennt 24 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND There is a lack of studies reporting long-term outcomes in patients surviving initial event of acute mesenteric ischemia (AMI). AIM To identify population-based outcomes and risk factors for mortality according to AMI subtypes. METHODS We performed overall survival analysis of all enrolled AMI patients and follow-up investigation on patients who survived beyond index admission. The demographics, diagnostic and management variables, in addition to causes of death, were accrued from the Estonian National Electronic Health Database and medical records between 2016 and 2024. Risk factors for mortality were analyzed using univariable and multivariable analyses for all AMI patients and separately for patients with superior mesenteric artery thrombosis. Survival curves were calculated using Kaplan–Meier estimators. RESULTS In total, 572 patients were analyzed for overall survival. There were 203 patients discharged alive after an AMI event, with a median age of 74 years (range 64–80 years) and a median follow-up time of 39 months (interquartile range 10–63 months). Overall 3-year and estimated 5-year survival was 19.2% and 15.6%, while 3-year and estimated 5-year survival of the discharged patients was 54.2% and 44.2%, respectively. Survival curves for all patients diverged between AMI subtypes, with improved survival in patients with superior mesenteric vein occlusion. The 3-year and estimated 5-year survival curves of discharged patients did not differ between the subtypes of AMI, however, the estimated 8-year survival curves showed improved survival in patients with nonocclusive mesenteric ischemia and superior mesenteric vein occlusion. The main cause of death after discharge (44.3%) was another cardiovascular event. Multivariable analysis including all discharged patients, revealed advanced age, disability, and high Charlson’s comorbidity index as significant risk factors and antithrombotic therapy as protective factors for mortality. CONCLUSION Risk factors for mortality for all patients were advanced age, disability, comorbidity, and lack of antithrombotic therapy. In superior mesenteric artery thrombosis, post-discharge antithrombotic therapy was associated with improved long-term survival, but this requires prospective validation, and optimal antithrombotic strategies still necessitate individualized evaluation.

Zitieren

APA

Kase, K., Koitmäe, M., Blaser, A. R., Tamme, K., Talving, P., & Murruste, M. (2026). Long-term outcomes following successful treatment of acute mesenteric ischemic event: A population-based observational study. World Journal of Gastrointestinal Surgery, 18(8). https://doi.org/10.4240/wjgs.118103

Vancouver

Kase K, Koitmäe M, Blaser AR, Tamme K, Talving P, Murruste M. Long-term outcomes following successful treatment of acute mesenteric ischemic event: A population-based observational study. World Journal of Gastrointestinal Surgery. 2026;18(8). doi:10.4240/wjgs.118103

BibTeX
@article{Kase2026,
  author = {Kase, Karri and Koitmäe, Merli and Blaser, Annika Reintam and Tamme, Kadri and Talving, Peep and Murruste, Marko},
  title = {Long-term outcomes following successful treatment of acute mesenteric ischemic event: A population-based observational study},
  journal = {World Journal of Gastrointestinal Surgery},
  year = {2026},
  volume = {18},
  number = {8},
  doi = {10.4240/wjgs.118103}
}
Kostenlos starten →